Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347444
What this trial is testing
Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma
Who this might be right for
Acral MelanomaMucosal Melanoma
Fudan University 48